₹ 458.60
-13.05 (-2.77%)
C
Cohance Lifesciences
₹ 458.60
Cohance Lifesciences EPS Summary (consolidated)
The latest quarterly EPS of Cohance Lifesciences as of Q2 Sep 2026 stands at ₹0.40. This is a 163.49% growth quarter on quarter and 79.38% fall same quarter last year. The forecasted EPS for Q2 Sep 2026 was ₹0.05. It beat the estimate by ₹0.35. For the FY2026 the EPS of Cohance Lifesciences stands at ₹4.69. This is a 63.33% fall compared with FY2025.
Cohance Lifesciences EPS
EPS by Peers

S
Sun Pharmaceutical

D
Divis Laboratories

T
Torrent Pharmaceuticals

L
Laurus Labs

Z
Zydus Life Science
*Based on consolidated figures.

Pay Zero Brokerage on Delivery
Open FREE Demat Account
+91
Or Scan the QR Code to download the Dhan App

